UAE Approves Biomerica’s Home Kidney Test
The test detects early albumin markers in urine within 10 minutes, targeting high-risk diabetes and hypertension patients.
The test detects early albumin markers in urine within 10 minutes, targeting high-risk diabetes and hypertension patients.
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
The DNA-based stool screening test is now authorized for marketing through the MHRA, expanding access to non-invasive CRC detection.
The exclusive partnership will bring Sonrai Discovery's precision medicine capabilities to SmartLabs' network of managed research centers.
The test demonstrated higher baseline sensitivity for ctDNA detection compared to gene mutation-based testing in AstraZeneca's NeoADAURA study.